Off-label use of antipsychotic drugs

被引:47
|
作者
Weiss, E
Hummer, M
Koller, D
Ulmer, H
Fleischhacker, WW
机构
[1] Univ Clin Innsbruck, Dept Biol Psychiat, A-6020 Innsbruck, Austria
[2] Univ Clin Innsbruck, Inst Biostat, A-6020 Innsbruck, Austria
关键词
D O I
10.1097/00004714-200012000-00018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the fact that most antipsychotics have only been formally evaluated for the treatment of schizophreniform disorder, schizophrenia, mania, and schizoaffective disorder (defined as "classical indications"), antipsychotics are widely used for the treatment of a broad range of symptoms and disorders. In this study, 173 patients who were having their prescriptions for antipsychotics filled at local pharmacies were interviewed. In 115 patients (66.5%), an antipsychotic was prescribed for off-label indications. Patients most often stated that they took antipsychotics as a tranquilizer or an anxiolytic. Neither gender, education, duration of treatment, nor efficacy of treatment showed an influence on the prescription practices for antipsychotics. In contrast, family status and side effects showed a significant influence. A classical indication was more often found in married and widowed patients than in unmarried or divorced ones. Patients in whom antipsychotics were prescribed for the treatment of schizophrenia, schizophreniform disorder, mania, or schizoaffective disorder experienced side effects more often than others. Age was also important for the indication of antipsychotics. Classical indications of antipsychotics were most often found in patients aged 30 to 49 years. In older patients (49-70 years), antipsychotics were almost exclusively used for off-label indications. In classical indications, clozapine was used more frequently (50%) than other antipsychotics. Melperone was primarily prescribed for off-label use.
引用
收藏
页码:695 / 698
页数:4
相关论文
共 50 条
  • [1] Off-label use of antipsychotic drugs
    Hummer, M
    Koller, D
    Hofer, A
    Ulmer, H
    Fleischhacker, WW
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 161 - 161
  • [2] Off-Label Use of Antipsychotic Drugs in Patients With Dementia
    Rice, James
    Humphreys, Candi
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2014, 10 (03): : 200 - 204
  • [3] FDA warns against off-label use of antipsychotic drugs
    Huntzinger, A
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (11) : 2205 - 2205
  • [4] The use of "off-label"' drugs
    Broadman, LM
    Semenov, I
    ANESTHESIA AND ANALGESIA, 2006, 103 (01): : 250 - 251
  • [5] Off-Label Use of Antipsychotic Drugs in Privately and Publicly Insured Youth in the US
    Crystal, Stephen
    Gerhard, Tobias
    Huang, Cecilia
    Olfson, Mark
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S195 - S196
  • [6] Off-Label Use of Antipsychotic Medications in Medicaid
    Leslie, Douglass L.
    Rosenheck, Robert
    AMERICAN JOURNAL OF MANAGED CARE, 2012, 18 (03): : E109 - E117
  • [7] Off-label use of approved drugs
    Landow, L
    CHEST, 1999, 116 (03) : 589 - 591
  • [8] Off-Label Use of Drugs and Devices
    Rosenfeld, Philip J.
    Goodman, Kenneth W.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 170 - 171
  • [9] Guidance for off-label use of drugs
    不详
    LANCET NEUROLOGY, 2008, 7 (04): : 285 - 285
  • [10] Controlled use of off-label drugs
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) : 1189 - 1189